Harris Williams Expands European Presence with Appointment of Dr. Julian Feneley as Managing Director, Healthcare and Life Sciences | Business


RICHMOND, Va.–(BUSINESS WIRE)–January 20, 2022–

Harris Williams, a global investment bank specializing in M&A advisory services, today announced that Dr Julian Feneley has joined the firm’s London office as Managing Director, Healthcare and Life Sciences (HCLS). Dr. Feneley brings nearly 30 years of experience in the healthcare and life sciences industry to Harris Williams and will lead HCLS’ European efforts, drawing on the firm’s expertise in key verticals. of the group, including pharmaceutical services, medical devices and many segments of healthcare providers.

“We are delighted to welcome Julian to Harris Williams as we continue to expand our global platform,” said Bob Baltimore and John Neuner, co-heads of mergers and acquisitions at Harris Williams. “As a seasoned and trusted advisor and proven industry leader, Julian brings an in-depth understanding of the healthcare landscape and the universe of sponsors and companies globally, which is essential for navigating the an increasingly active and dynamic sector. Additionally, Julian values ​​our firm’s culture of collaboration and integrity, and we look forward to his many contributions as we further strengthen our ability to meet growing client demand across Europe.

“Harris Williams has an exceptional reputation for creating value for his clients, and I am delighted to join his insightful and dedicated team at this exciting time in the company’s growth,” said Dr. Feneley. “I look forward to collaborating with my new colleagues as the firm continues to build its global presence.”

Cheairs Porter and Geoff Smith, co-heads of Harris Williams’ Healthcare and Life Sciences group, added: “The sustained and robust expansion of healthcare and life sciences globally requires industry relations depth, expertise and execution capabilities that Julian brings to our growth. European company. We believe that our unrivaled industry knowledge and unwavering commitment to client service uniquely positions us to guide our corporate clients and financial sponsors as they seek to capitalize on attractive opportunities around the world.

Dr Feneley was most recently Managing Director and Head of European Healthcare at Macquarie Capital (the investment banking division of the Macquarie Group). His previous experience includes serving as Head of European Healthcare Investment Banking at Canaccord Genuity Inc. after leading European Healthcare Investment Banking at JP Morgan. He was also CEO of BriteSmile Inc, a leading US dental technology company that served over 7,000 dental practice customers worldwide. Dr. Feneley graduated with MBBS (Medical) and B.Sc (Science) degrees from the University of London (Guy’s Hospital).

Harris Williams’ HCLS Group is dedicated to understanding the complex dynamics of the industry and providing superior M&A advisory services to companies operating within it. The HCLS Group has deep experience across a wide range of industries, including healthcare providers, payers and payer services, outsourced pharmaceutical services, medical device supply chain, healthcare IT and the pharmacy.

For more information about Harris Williams’ HCLS group, please visit: https://www.harriswilliams.com/industries/healthcare-and-life-sciences.

About Harris Williams

Harris Williams, an investment bank specializing in M&A advisory services, defends sellers and buyers of businesses around the world through critical stages and provides expert advice throughout the life of their businesses . By collaborating as one company across industry groups and geographies, the company helps its clients achieve results that support their goals and strategically create value. Harris Williams is committed to excellence in execution and to building lasting and valuable relationships based on mutual trust. Harris Williams is a subsidiary of PNC Financial Services Group, Inc. (NYSE: PNC).

Harris Williams LLC is a registered broker and member of FINRA and SIPC. Harris Williams & Co. Ltd is a limited company incorporated under the laws of England with its registered office at 8th Floor, 20 Farringdon Street, London EC4A 4AB, United Kingdom, registered with the Registrar of Companies for England and Wales (registration number registration 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. Corporate Finance Advisors GmbH is registered in the commercial register of the local court in Frankfurt am Main, Germany under number HRB 107540. The registered address is Bockenheimer Landstrasse 33-35, 60325 Frankfurt am Main. -le-Main, Germany (e-mail address: [email protected] ). Geschäftsführer/Directors: Jeffery H. Perkins, Paul Poggi. (VAT number DE321666994). Harris Williams is a trading name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH operate.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220120005320/en/


Julia Moore

media@harriswilliams.comNathaniel Garnick/Mark Semer/Kevin FitzGerald

Gasthalter & Cie.

(212) 257-4170

[email protected]



SOURCE: Harris Williams

Copyright BusinessWire 2022.

PUBLISHED: 01/20/2022 07:00/DISC: 01/20/2022 07:02


Copyright BusinessWire 2022.


Comments are closed.